AbbVie to Buy ImmunoGen for More Than $10 Billion
Wall Street Journal
AbbVie has agreed to buy ImmunoGen for about $10.1 billion in a deal that speeds the biopharmaceutical company’s entry into the commercial market for ovarian cancer.
https://www.wsj.com/articles/abbvie-to-buy-immunogen-for-more-than-10-billion-5e942e18